KBC Group NV Sells 224,828 Shares of Elanco Animal Health Incorporated (NYSE:ELAN)

KBC Group NV cut its holdings in Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) by 69.5% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 98,674 ... Read More

Why Elanco (ELAN) Stock Is Trading Lower Today

What Happened? Shares of animal health company Elanco (NYSE:ELAN) fell 4.1% in the afternoon session after competitor Boehringer Ingelheim announced the U.S. launch of a new, advanced vaccine for ... Read More

What Makes Elanco Animal Health (ELAN) a New Buy Stock

Elanco Animal Health Incorporated (ELAN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ... Read More

What is Leerink Partnrs’ Estimate for ELAN FY2025 Earnings?

Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) – Investment analysts at Leerink Partnrs increased their FY2025 earnings per share estimates for Elanco Animal Health in a research report ... Read More

Elanco Animal Health Incorporated (ELAN) Q2 2025 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health Second Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to Tiffany ... Read More

Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise

Elanco’s recent launches could add 5% to overall growth in 2025, per William Blair. EMA panel gives positive opinion on Zenrelia; approval expected by Q3 end. Get special access to three exclusive ... Read More

Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates

Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.3 per share a year ... Read More

Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy

I rate Elanco Animal Health Incorporated shares a Buy with a $20 fair value, driven by strong innovation and recent operational improvements. Elanco's focus on innovative products like Zenrelia and ... Read More

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco posted Q2 sales of $1.24 billion, beating estimates and growing 5% YoY; adjusted EPS was $0.26, down 13% YoY. Pet Health revenue rose 11% to $643 million; Seresto and Advantage lines ... Read More